Guangyao Zhou

机构：Tianjin Medical University Cancer Institute and Hospital · ORCID：0000-0002-8966-4617

发表论文 33 篇 · 总被引 319 次 · h-index 6

代表论文

• Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma (2024 · Journal for ImmunoTherapy of Cancer · 被引 80)
• Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 79)
• Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing (2024 · Frontiers in Immunology · 被引 48)
• Purine metabolism in lung adenocarcinoma: A single‐cell analysis revealing prognostic and immunotherapeutic insights (2024 · Journal of Cellular and Molecular Medicine · 被引 30)
• Clinical prognostication and immunotherapy response prediction in esophageal squamous cell carcinoma using the DNA damage repair‐associated signature (2024 · Environmental Toxicology · 被引 30)
• Space is a latent sequence: A theory of the hippocampus (2024 · Science Advances · 被引 28)